CIK 0001662774
- Non-accelerated filer
- Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 901024039
- Phone
- +1 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Executive or director change
- 8-K Event Material agreement · New debt or obligation · Executive or director change
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Results of operations · New debt or obligation · Unregistered share sale · Executive or director change · Regulation FD disclosure · Other events
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Executive or director change
- 8-K Event Results of operations · Exit or restructuring costs · Other events
- 8-K Event Material agreement · Executive or director change
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Bylaws or fiscal year change · Other events
- 8-K Event Executive or director change
- 8-K Event Material agreement · New debt or obligation · Executive or director change · Shareholder vote results
Page 4 of 6 · 116 filings